103 related articles for article (PubMed ID: 19750515)
1. Upc2p-associated differential protein expression in Candida albicans.
Hoehamer CF; Cummings ED; Hilliard GM; Morschhäuser J; David Rogers P
Proteomics; 2009 Oct; 9(20):4726-30. PubMed ID: 19750515
[TBL] [Abstract][Full Text] [Related]
2. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Dunkel N; Liu TT; Barker KS; Homayouni R; Morschhäuser J; Rogers PD
Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
[TBL] [Abstract][Full Text] [Related]
3. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
Heilmann CJ; Schneider S; Barker KS; Rogers PD; Morschhäuser J
Antimicrob Agents Chemother; 2010 Jan; 54(1):353-9. PubMed ID: 19884367
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain.
Yan L; Zhang JD; Cao YB; Gao PH; Jiang YY
J Proteome Res; 2007 Jun; 6(6):2248-56. PubMed ID: 17432892
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro MA; Paula CR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
[TBL] [Abstract][Full Text] [Related]
6. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
Sasse C; Dunkel N; Schäfer T; Schneider S; Dierolf F; Ohlsen K; Morschhäuser J
Mol Microbiol; 2012 Nov; 86(3):539-56. PubMed ID: 22924823
[TBL] [Abstract][Full Text] [Related]
7. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
8. Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals.
Manastır L; Ergon MC; Yücesoy M
Mycoses; 2011 Mar; 54(2):99-104. PubMed ID: 19732347
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
Xu Y; Wang Y; Yan L; Liang RM; Dai BD; Tang RJ; Gao PH; Jiang YY
J Proteome Res; 2009 Nov; 8(11):5296-304. PubMed ID: 19754040
[TBL] [Abstract][Full Text] [Related]
12. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.
Hiller D; Stahl S; Morschhäuser J
Antimicrob Agents Chemother; 2006 Jul; 50(7):2300-8. PubMed ID: 16801405
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
Flowers SA; Barker KS; Berkow EL; Toner G; Chadwick SG; Gygax SE; Morschhäuser J; Rogers PD
Eukaryot Cell; 2012 Oct; 11(10):1289-99. PubMed ID: 22923048
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
15. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
16. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
17. An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans.
Hoot SJ; Smith AR; Brown RP; White TC
Antimicrob Agents Chemother; 2011 Feb; 55(2):940-2. PubMed ID: 21078937
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of experimentally induced azole resistance in Candida glabrata.
Rogers PD; Vermitsky JP; Edlind TD; Hilliard GM
J Antimicrob Chemother; 2006 Aug; 58(2):434-8. PubMed ID: 16735426
[TBL] [Abstract][Full Text] [Related]
19. The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance.
Oliveira Carvalho V; Okay TS; Melhem MS; Walderez Szeszs M; del Negro GM
Rev Iberoam Micol; 2013; 30(3):209-12. PubMed ID: 23402828
[TBL] [Abstract][Full Text] [Related]
20. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
